AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
Levocetirizine/Montelukast in Ghana
6 products registered with FDA Ghana — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| LEVOCET-M TABLETS (Each tablet contains Levocetirizine/Montelukast -5mg/10mg) | UNKNOWN-bddd22e6 | — | active | 1 Apr 2031 |
| LEVOCET-M TABLETS (Each tablet contains Levocetirizine/Montelukast -5mg/10mg) | UNKNOWN-411fe681 | — | active | 1 Apr 2031 |
| TELOVA TABLETS | UNKNOWN-227382d9 | — | active | 1 Jun 2027 |
| TELOVA TABLETS | UNKNOWN-68752420 | — | active | 1 Jun 2027 |
| TELOVA SYRUP | UNKNOWN-514103f3 | — | active | 1 May 2027 |
| TELOVA SYRUP | UNKNOWN-b9ed83a8 | — | active | 1 May 2027 |
Levocetirizine/Montelukast — FDA Ghana Registration Details
FDA Ghana (Ghana) has 6 registered products containing Levocetirizine/Montelukast, of which 6 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track Levocetirizine/Montelukast registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.